All Issue

2024 Vol.54, Issue 4 Preview Page

Review Article

31 December 2024. pp. 273-283
Abstract
References
1

Johansen MD, Herrmann JL, Kremer L. Non-tuberculous mycobacteria and the rise of Mycobacterium abscessus. Nat Rev Microbiol. 2020;18(7):392-407.

10.1038/s41579-020-0331-132086501
2

Bhargava A, Bhargava M. Tuberculosis deaths are predictable and preventable: Comprehensive assessment and clinical care is the key. J Clin Tuberc Other Mycobact Dis. 2020;19:100155.

10.1016/j.jctube.2020.10015532211519PMC7082610
3

Bagcchi S. WHO's Global Tuberculosis Report 2022. Lancet Microbe. 2023;4(1):e20.

10.1016/S2666-5247(22)00359-736521512
4

Dailloux M, Abalain ML, Laurain C, Lebrun L, Loos-Ayav C, Lozniewski A, et al. Respiratory infections associated with nontuberculous mycobacteria in non-HIV patients. Eur Respir J. 2006;28(6):1211-1215.

10.1183/09031936.0006380617138678
5

Adjemian J, Olivier KN, Seitz AE, Holland SM, Prevots DR. Prevalence of nontuberculous mycobacterial lung disease in U.S. Medicare beneficiaries. Am J Respir Crit Care Med. 2012;185(8):881-886.

10.1164/rccm.201111-2016OC22312016PMC3360574
6

Harada K, Hagiya H, Funahashi T, Koyama T, Kano MR, Otsuka F. Trends in the Nontuberculous Mycobacterial Disease Mortality Rate in Japan: A Nationwide Observational Study, 1997-2016. Clin Infect Dis. 2021;73(2):e321-e326.

10.1093/cid/ciaa81032556251
7

Falkinham JO. 3rd. Environmental sources of nontuberculous mycobacteria. Clin Chest Med. 2015;36(1):35-41.

10.1016/j.ccm.2014.10.00325676517
8

Gopalaswamy R, Shanmugam S, Mondal R, Subbian S. Of tuberculosis and non-tuberculous mycobacterial infections - a comparative analysis of epidemiology, diagnosis and treatment. J Biomed Sci. 2020;27(1):74.

10.1186/s12929-020-00667-632552732PMC7297667
9

Kim BJ, Hong SH, Kook YH, Kim BJ. Mycobacterium paragordonae sp. nov., a slowly growing, scotochromogenic species closely related to Mycobacterium gordonae. Int J Syst Evol Microbiol. 2014;64(Pt 1):39-45.

10.1099/ijs.0.051540-024006480
10

Kim BJ, Kim BR, Kook YH, Kim BJ. A temperature sensitive Mycobacterium paragordonae induces enhanced protective immune responses against mycobacterial infections in the mouse model. Sci Rep. 2017;7(1):15230.

10.1038/s41598-017-15458-729123166PMC5680210
11

Kim BJ, Jeong H, Seo H, Lee MH, Shin HM, Kim BJ. Recombinant Mycobacterium paragordonae Expressing SARS-CoV-2 Receptor-Binding Domain as a Vaccine Candidate Against SARS-CoV-2 Infections. Front Immunol. 2021;12:712274.

10.3389/fimmu.2021.71227434512635PMC8432291
12

Kim BJ, Kim BR, Kook YH, Kim BJ. Potential of recombinant Mycobacterium paragordonae expressing HIV-1 Gag as a prime vaccine for HIV-1 infection. Sci Rep. 2019;9(1):15515.

10.1038/s41598-019-51875-631664100PMC6820866
13

Lee MH, Kim BR, Seo H, Oh J, Kim HL, Kim BJ. Live Mycobacterium paragordonae induces heterologous immunity of natural killer cells by eliciting type I interferons from dendritic cells via STING-dependent sensing of cyclic-di-GMP. Microbes Infect. 2023;25(7):105144.

10.1016/j.micinf.2023.10514437120009
14

Lee MH, Seo H, Lee MS, Kim BJ, Kim HL, Lee DH, et al. Protection against tuberculosis achieved by dissolving microneedle patches loaded with live Mycobacterium paragordonae in a BCG prime-boost strategy. Front Immunol. 2023;14:1178688.

10.3389/fimmu.2023.117868837398665PMC10312308
15

Ziogas A, Netea MG. Trained immunity-related vaccines: innate immune memory and heterologous protection against infections. Trends Mol Med. 2022;28(6):497-512.

10.1016/j.molmed.2022.03.00935466062
16

Kim BJ, Cha GY, Kim BR, Kook YH, Kim BJ. Insights From the Genome Sequence of Mycobacterium paragordonae, a Potential Novel Live Vaccine for Preventing Mycobacterial Infections: The Putative Role of Type VII Secretion Systems for an Intracellular Lifestyle Within Free-Living Environmental Predators. Front Microbiol. 2019;10:1524.

10.3389/fmicb.2019.0152431333625PMC6616192
17

Pereira SG, Alarico S, Tiago I, Reis D, Nunes-Costa D, Cardoso O, et al. Studies of antimicrobial resistance in rare mycobacteria from a nosocomial environment. BMC Microbiol. 2019;19(1):62.

10.1186/s12866-019-1428-430890149PMC6425705
18

Moradi S, Nasiri MJ, Pourahmad F, Darban-Sarokhalil D. Molecular characterization of nontuberculous mycobacteria in hospital waters: a two-year surveillance study in Tehran, Iran. J Water Health. 2019;17(2):350-356.

10.2166/wh.2019.29430942784
19

Takajo I, Iwao C, Aratake M, Nakayama Y, Yamada A, Takeda N, et al. Pseudo-outbreak of Mycobacterium paragordonae in a hospital: possible role of the aerator/rectifier connected to the faucet of the water supply system. J Hosp Infect. 2020;104(4):545-551.

10.1016/j.jhin.2019.11.01431785317
20

Arfaatabar M, Karami P, Khaledi A. An update on prevalence of slow-growing mycobacteria and rapid-growing mycobacteria retrieved from hospital water sources in Iran - a systematic review. Germs. 2021;11(1):97-104.

10.18683/germs.2021.124533898346PMC8057855
21

Cheung CY, Cheng NHY, Ting WM, Chak WL. Mycobacterium paragordonae: a rare cause of peritonitis in a peritoneal dialysis patient. Clin Nephrol. 2017;88(12):371-372.

10.5414/CN10927229057736
22

Kaelin MB, Kuster SP, Hasse B, Schulthess B, Imkamp F, Halbe M, et al. Diversity of nontuberculous mycobacteria in Heater-Cooler Devices - results from prospective surveillance. J Hosp Infect. 2020:S0195-6701(20)30105-5.

23

Li Y, Zhang W, Zhao J, Lai W, Zhao Y, Li Y, et al. Mycobacterium paragordonae is an emerging pathogen in human pulmonary disease: clinical features, antimicrobial susceptibility testing and outcomes. Emerg Microbes Infect. 2022;11(1):1973-1981.

10.1080/22221751.2022.210345335916253PMC9364734
24

Azadi D, Shojaei H, Pourchangiz M, Dibaj R, Davarpanah M, Naser AD. Species diversity and molecular characterization of nontuberculous mycobacteria in hospital water system of a developing country, Iran. Microb Pathog. 2016;100:62-69.

10.1016/j.micpath.2016.09.00427616445
25

Cohn ML, Waggoner RF, McClatchy JK. The 7H11 medium for the cultivation of mycobacteria. Am Rev Respir Dis. 1968;98(2):295-296.

26

Hines N, Payeur JB, Hoffman LJ. Comparison of the recovery of Mycobacterium bovis isolates using the BACTEC MGIT 960 system, BACTEC 460 system, and Middlebrook 7H10 and 7H11 solid media. J Vet Diagn Invest. 2006;18(3):243-250.

10.1177/10406387060180030216789711
27

Bespyatykh JA, Manicheva OA, Smolyakov AV, Dogonadze MZ, Zhuravlev VY, Shitikov EA, et al. Influence of cultivation conditions on the proteomic profile of Mycobacterium tuberculosis H37RV. Biomed Khim. 2017;63(4):334-340.

10.18097/PBMC2017630433428862605
28

Cha GY, Seo H, Oh J, Kim BJ, Kim BJ. Potential Use of Mycobacterium paragordonae for Antimycobacterial Drug Screening Systems. J Microbiol. 2023;61(1):121-129.

10.1007/s12275-022-00009-136719620
29

Pym AS, Brodin P, Majlessi L, Brosch R, Demangel C, Williams A, et al. Recombinant BCG exporting ESAT-6 confers enhanced protection against tuberculosis. Nat Med. 2003;9(5):533-539.

10.1038/nm85912692540
30

Pooransingh S, Sakhamuri S. Need for BCG Vaccination to Prevent TB in High-Incidence Countries and Populations. Emerg Infect Dis. 2020;26(3):624-625.

10.3201/eid2603.19123231922950PMC7045831
31

Stoitzner P, Tripp CH, Douillard P, Saeland S, Romani N. Migratory Langerhans cells in mouse lymph nodes in steady state and inflammation. J Invest Dermatol. 2005;125(1):116-125.

10.1111/j.0022-202X.2005.23757.x15982311
32

Kissenpfennig A, Henri S, Dubois B, Laplace-Builhé C, Perrin P, Romani N, et al. Dynamics and function of Langerhans cells in vivo: dermal dendritic cells colonize lymph node areas distinct from slower migrating Langerhans cells. Immunity. 2005;22(5):643-654.

10.1016/j.immuni.2005.04.00415894281
33

Han SJ, Song T, Cho YJ, Kim JS, Choi SY, Bang HE, et al. Complete genome sequence of Mycobacterium tuberculosis K from a Korean high school outbreak, belonging to the Beijing family. Stand Genomic Sci. 2015;10:78.

10.1186/s40793-015-0071-426473025PMC4606834
34

Kleinnijenhuis J, Quintin J, Preijers F, Joosten LA, Ifrim DC, Saeed S, et al. Bacille Calmette-Guerin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes. Proc Natl Acad Sci U S A. 2012;109(43):17537-17542.

10.1073/pnas.120287010922988082PMC3491454
35

Tarancón R, Domínguez-Andrés J, Uranga S, Ferreira AV, Groh LA, Domenech M, et al. New live attenuated tuberculosis vaccine MTBVAC induces trained immunity and confers protection against experimental lethal pneumonia. PLoS Pathog. 2020;16(4):e1008404.

10.1371/journal.ppat.100840432240273PMC7117655
36

Mata E, Tarancon R, Guerrero C, Moreo E, Moreau F, Uranga S, et al. Pulmonary BCG induces lung-resident macrophage activation and confers long-term protection against tuberculosis. Sci Immunol. 2021;6(63):eabc2934.

10.1126/sciimmunol.abc293434559551
37

Leentjens J, Kox M, Stokman R, Gerretsen J, Diavatopoulos DA, van Crevel R, et al. BCG Vaccination Enhances the Immunogenicity of Subsequent Influenza Vaccination in Healthy Volunteers: A Randomized, Placebo-Controlled Pilot Study. J Infect Dis. 2015;212(12):1930-1938.

10.1093/infdis/jiv33226071565
38

Mukherjee S, Subramaniam R, Chen H, Smith A, Keshava S, Shams H. Boosting efferocytosis in alveolar space using BCG vaccine to protect host against influenza pneumonia. PLoS One. 2017;12(7):e0180143.

10.1371/journal.pone.018014328686604PMC5501455
39

Spencer JC, Ganguly R, Waldman RH. Nonspecific protection of mice against influenza virus infection by local or systemic immunization with Bacille Calmette-Guérin. J Infect Dis. 1977;136(2):171-175.

10.1093/infdis/136.2.171894076
40

Arts RJW, Moorlag S, Novakovic B, Li Y, Wang SY, Oosting M, et al. BCG Vaccination Protects against Experimental Viral Infection in Humans through the Induction of Cytokines Associated with Trained Immunity. Cell Host Microbe. 2018;23(1):89-100.e5.

10.1016/j.chom.2017.12.01029324233
41

Burdette DL, Monroe KM, Sotelo-Troha K, Iwig JS, Eckert B, Hyodo M, et al. STING is a direct innate immune sensor of cyclic di-GMP. Nature. 2011;478(7370):515-518.

10.1038/nature1042921947006PMC3203314
42

Chang WL, Barry PA, Szubin R, Wang D, Baumgarth N. Human cytomegalovirus suppresses type I interferon secretion by plasmacytoid dendritic cells through its interleukin 10 homolog. Virology. 2009;390(2):330-337.

10.1016/j.virol.2009.05.01319524994PMC2747589
43

Madera S, Rapp M, Firth MA, Beilke JN, Lanier LL, Sun JC. Type I IFN promotes NK cell expansion during viral infection by protecting NK cells against fratricide. J Exp Med. 2016;213(2):225-233.

10.1084/jem.2015071226755706PMC4749923
44

Lee SY, Yang SB, Choi YM, Oh SJ, Kim BJ, Kook YH, et al. Heat-killed Mycobacterium paragordonae therapy exerts an anti-cancer immune response via enhanced immune cell mediated oncolytic activity in xenograft mice model. Cancer Lett. 2020;472:142-150.

10.1016/j.canlet.2019.12.02831874244
45

Azadi D, Shojaei H, Mobasherizadeh S, Naser AD. Screening, isolation and molecular identification of biodegrading mycobacteria from Iranian ecosystems and analysis of their biodegradation activity. AMB Express. 2017;7(1):180.

10.1186/s13568-017-0472-428933031PMC5607059
46

Rivera-Calzada A, Famelis N, Llorca O, Geibel S. Type VII secretion systems: structure, functions and transport models. Nat Rev Microbiol. 2021;19(9):567-584.

10.1038/s41579-021-00560-534040228
47

Shen Y, Haig SJ, Prussin AJ, 2nd, LiPuma JJ, Marr LC, Raskin L. Shower water contributes viable nontuberculous mycobacteria to indoor air. PNAS Nexus. 2022;1(5):pgac145.

10.1093/pnasnexus/pgac14536712351PMC9802317
48

Maleki MR, Kafil HS, Harzandi N, Moaddab SR. Identification of nontuberculous mycobacteria isolated from hospital water by sequence analysis of the hsp65 and 16S rRNA genes. J Water Health. 2017;15(5):766-774.

10.2166/wh.2017.04629040079
49

Machida Y, Tang BCC, Yamada M, Sato S, Nakajima K, Matoyama H, et al. Mycobacteriosis in cultured koi carp Cyprinus carpio caused by Mycobacterium paragordonae and two Mycolicibacterium spp. Aquaculture. 2021;539:736656.

10.1016/j.aquaculture.2021.736656
50

Jinah R, Ryan T, Sibbald M. A Case of Pericarditis and Pericardial Masses Associated With Mycobacterium paragordonae. Clin Med Insights Cardiol. 2023;17:11795468231189039.

10.1177/1179546823118903937637260PMC10460162
51

Zou Y, Wu YC, Korman A. S2714 Case Report: Mycobacterium paragordonae Associated Crohn's Disease. The American Journal of Gastroenterology. 2022;117(10S):e1787.

10.14309/01.ajg.0000867496.96241.cb
52

Karim A, Fnu Z. MYCOBACTERIUM PARAGORDONEA: A CAUSE OF HEMOPTYSIS? Monday Medical Student/Resident Case Report Posters. 2019;156(4).

10.1016/j.chest.2019.08.729
53

Tan YZ, Yuan T, Tan L, Tian YQ, Long YZ. Lumbar infection caused by Mycobacterium paragordonae: A case report. World J Clin Cases. 2021;9(29):8879-8887.

10.12998/wjcc.v9.i29.887934734070PMC8546838
54

Singh D, Sit S, Singh N. Diagnostic and therapeutic dilemma of cervical adenitis in an adult. BMJ Case Reports. 2022;15(9):e247303.

10.1136/bcr-2021-247303PMC9462124
55

2022 Annual Conference Conférence Annuelle. J Assoc Med Microbiol Infect Dis Can. 2022;7(s1):1-131.

10.3138/jammi.7.s1.abst
Information
  • Publisher :The Korean Society for Microbiology and The Korean Society of Virology
  • Publisher(Ko) :대한미생물학회‧대한바이러스학회
  • Journal Title :JOURNAL OF BACTERIOLOGY AND VIROLOGY
  • Volume : 54
  • No :4
  • Pages :273-283
  • Received Date : 2024-08-26
  • Revised Date : 2024-10-02
  • Accepted Date : 2024-10-07